Clinical Trials Logo

Diastolic Dysfunction clinical trials

View clinical trials related to Diastolic Dysfunction.

Filter by:

NCT ID: NCT04584203 Recruiting - Critical Illness Clinical Trials

Diastolic dYsfunctioN AssessMent in critICally Ill Patients

DYNAMIC
Start date: June 1, 2021
Phase:
Study type: Observational

The role of the left ventricular diastolic function (LVDD) in the weaning failure from mechanical ventilation in unclear. Specifically, is unclear whether the outcome of the weaning process could be affected by a pre-existing LVDD (before ICU admission), or by the worsening of a chronic pattern, or by a de-novo LVDD presentation.

NCT ID: NCT04558450 Recruiting - Covid19 Clinical Trials

Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)

CARTESIAN
Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.

NCT ID: NCT04190420 Enrolling by invitation - Hypertension Clinical Trials

The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study

Start date: October 1, 2018
Phase:
Study type: Observational

AIMS Despite evidence-based therapeutic approaches, target blood pressure is obtained by less than half of patients with hypertension. Hypertension is associated with a significant risk for heart failure (HF), in particular HF with preserved left ventricular (LV) ejection fraction (HFpEF). Although treatment is suggested to be given early after hypertension diagnosis, there is still no evidence-based medical treatment for HFpEF. We aim to study the underlying mechanisms behind the transition from uncomplicated hypertension to hypertensive heart disease (HHD) and HFpEF. To this end, we will combine cardiac imaging techniques and measurements of circulating fibrosis markers to longitudinally monitor fibrosis development in patients with hypertension. METHODS In a prospective cohort study, 250 patients with primary hypertension and 60 healthy controls, will be characterized at inclusion, and after 1 and 6 years. Doppler-echocardiography, cardiac magnetic resonance imaging (CMR) and ECG will be used for measures of cardiac structure and function over time. Blood biomarkers reflecting myocardial fibrosis, inflammation and endothelial dysfunction will be analysed. As a proxy for HFpEF development, the primary endpoint is to measure echocardiographic changes in LV function and structure (E/e´ and LAVI) and to relate these measures of LV filling to blood pressure, biomarkers, ECG and CMR. CONCLUSION We aim to study the timeline and transition from uncomplicated hypertension to HHD and HFpEF. In order to identify subjects prone to develop HHD and HFpEF, we want to find biomarkers and cardiac imaging variables to explain disease progression. Ultimately, we aim at finding new pathways to prevent HFpEF.

NCT ID: NCT04177225 Completed - Clinical trials for Diastolic Dysfunction

Effect of Diastolic Dysfunction on Dynamic Cardiac Monitors

Start date: February 7, 2019
Phase:
Study type: Observational

This investigator initiated, prospective, observational, single-center study is designed to assess whether dynamic monitors of cardiac function such as stroke volume variation (SVV) that have been shown to predict volume responsiveness differ in clinical utility between patients with and without diastolic dysfunction.

NCT ID: NCT04149990 Recruiting - Clinical trials for Myocardial Infarction

Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

ARNiAMI
Start date: October 12, 2018
Phase: Phase 2
Study type: Interventional

This study examines the effect of Entresto on central hemodynamic parameters during exercise in patients with diastolic dysfunction following acute myocardial infarction. Half of the patients will receive Entresto and the other half will receive placebo.

NCT ID: NCT04143997 Withdrawn - Clinical trials for Diastolic Dysfunction

Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery

Start date: November 1, 2019
Phase:
Study type: Observational

The purpose of this project is to evaluate parameters of diastolic dysfunction assessed by clinical echocardiogram in patients who have had recovery of systolic function.

NCT ID: NCT04128735 Completed - Morbid Obesity Clinical Trials

Diastolic Dysfunction in Morbidly Obese Patients Undergo Bariatric Surgery

Start date: October 30, 2019
Phase:
Study type: Observational

Morbidly obese patients are at risk for diastolic cardiac dysfunction, which can lead to adverse event, such as, diastolic heart failure postoperatively. Preoperative screening by transthoracic echocardiogram is difficult due to anatomical challenge, therefore the prevalence of this problem may be underestimated. The investigator would like to perform transesophageal echocardiogram in this group of patients after anesthesia induction to demonstrate the true prevalence of this syndrome.

NCT ID: NCT04117009 Recruiting - Clinical trials for Diastolic Dysfunction

Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction

Start date: November 1, 2019
Phase: Phase 4
Study type: Interventional

In this study ASA 1, 2 individuals with grade 1 or 2 diastolic dysfunction will be recruited to assess the effects of Remifentanil infusion on left ventricular function evaluated with transthoracic echocardiagraphy.

NCT ID: NCT04114474 Completed - Clinical trials for Diastolic Dysfunction

Pre-operative Focused Transthoracic Echocardiography for Prediction of Post-operative Cardiac Complications

Start date: October 1, 2017
Phase:
Study type: Observational

The extent focused transthoracic echocardiography when done pre-operatively to patients admitted for elective surgery and suspected to be at risk of cardiac disease specially the geriatric population can affect perioperative anesthetic management of these patients.

NCT ID: NCT04025996 Recruiting - Clinical trials for Diastolic Dysfunction

REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus

Start date: February 20, 2018
Phase:
Study type: Observational

Retinopathy may be associated with diastolic dysfunction and/or coronary flow reserve in the heart, and albuminuria in diabetic patients. The objective of this study is to examine the cross-sectional relationships of retinopathy with indices of left ventricular diastolic function, coronary flow reserve and urinary albumin excretion, among diabetic patients.